companiesSEC EDGAR
Outlook Therapeutics, Inc.
SEC EDGAR published this disclosure on 2026-08-18. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001104659-26-098415
cik1649989
company nameOutlook Therapeutics, Inc.
form10-Q